Fort Sheridan Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Fort Sheridan Advisors's AMGN Position: Q1 2026 in Review
Fort Sheridan Advisors increased its Amgen (AMGN) stake by 18% in Q1 2026, buying an estimated $452K and bringing the position to 8,433 shares worth $2.97M. The position accounts for 0.36% of the portfolio, ranked #51.
Fort Sheridan Advisors first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Fort Sheridan Advisors held 8,433 shares of Amgen worth $2.97M as of Q1 2026.
- Fort Sheridan Advisors bought 1,269 Amgen shares in Q1 2026, an estimated $452K.
- Amgen made up 0.36% of Fort Sheridan Advisors's portfolio in Q1 2026, its #51 holding.
- Fort Sheridan Advisors first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Fort Sheridan Advisors's 13F filing for Q1 2026, filed 6 May 2026.